Alkermes ALKS Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Alkermes in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alkermes's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alkermes's operating lease liabilities?
- Alkermes (ALKS) reported operating lease liabilities of $63.75M in Q1 2026.
- How has Alkermes's operating lease liabilities changed year-over-year?
- Alkermes's operating lease liabilities decreased by 6.0% year-over-year, from $67.81M to $63.75M.
- What is the long-term trend for Alkermes's operating lease liabilities?
- Over 5 years (2020 to 2025), Alkermes's operating lease liabilities has grown at a -11.9% compound annual growth rate (CAGR), from $119.46M to $63.25M.
- What does operating lease liabilities mean?
- The long-term portion of the company's financial obligations for leased assets.
- How do you interpret operating lease liabilities?
- An increase suggests expansion of physical footprint or equipment leasing, while a decrease may indicate lease expirations or a shift toward asset ownership.
- How does operating lease liabilities compare across companies?
- Biotech peers typically show moderate lease liabilities depending on their R&D facility footprint and manufacturing strategy.